Search research articles
Contact Us
Filters
Showing results (31-40 of 1,622) with videos related to
Page
of 163
Sort By:
Current Oncology Reports
|
May 15, 2007
Quality assurance in oncology
Maurie Markman
Lancet (London, England)
|
June 5, 2007
Human papillomavirus vaccines to prevent cervical cancer
Maurie Markman
Seminars in Oncology
|
January 16, 2007
Clinical efficacy supporting the role of intraperitoneal drug delivery in the primary chemotherapeutic management of small-volume residual advanced ovarian cancer
Maurie Markman
Journal of the Society for Integrative Oncology
|
May 22, 2007
Justification for separate consideration of two broad categories of cancer patient use of complementary medicine
Maurie Markman
Current Oncology Reports
|
October 17, 2006
Evaluation of the clinical utility of diagnostic versus therapeutic interventions in oncology: related but quite different processes
Maurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2004
Intraperitoneal hyperthermic chemotherapy as treatment of peritoneal carcinomatosis of colorectal cancer
Maurie Markman
Oncology
|
June 17, 2011
Cross-trial comparisons in the oncology arena: when is this justified?
Maurie Markman
Seminars in Oncology
|
August 1, 1989
Intraperitoneal cisplatin chemotherapy in the management of ovarian carcinoma
M Markman
Cancer Investigation
|
January 1, 1987
Clinical cancer research, DNR orders, and medical economics: a complex interrelationship
M Markman
Oncology
|
July 10, 2019
The Evolving Arena of Ovarian Cancer Maintenance Therapy
Maurie Markman
Page
of 163
Search research articles
Search
Showing results (31-40 of 1,622) with videos related to
Sort By:
Page
of 163
Current Oncology Reports
|
May 15, 2007
Quality assurance in oncology
Maurie Markman
Lancet (London, England)
|
June 5, 2007
Human papillomavirus vaccines to prevent cervical cancer
Maurie Markman
Seminars in Oncology
|
January 16, 2007
Clinical efficacy supporting the role of intraperitoneal drug delivery in the primary chemotherapeutic management of small-volume residual advanced ovarian cancer
Maurie Markman
Journal of the Society for Integrative Oncology
|
May 22, 2007
Justification for separate consideration of two broad categories of cancer patient use of complementary medicine
Maurie Markman
Current Oncology Reports
|
October 17, 2006
Evaluation of the clinical utility of diagnostic versus therapeutic interventions in oncology: related but quite different processes
Maurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2004
Intraperitoneal hyperthermic chemotherapy as treatment of peritoneal carcinomatosis of colorectal cancer
Maurie Markman
Oncology
|
June 17, 2011
Cross-trial comparisons in the oncology arena: when is this justified?
Maurie Markman
Seminars in Oncology
|
August 1, 1989
Intraperitoneal cisplatin chemotherapy in the management of ovarian carcinoma
M Markman
Cancer Investigation
|
January 1, 1987
Clinical cancer research, DNR orders, and medical economics: a complex interrelationship
M Markman
Oncology
|
July 10, 2019
The Evolving Arena of Ovarian Cancer Maintenance Therapy
Maurie Markman
Page
of 163